NCT01458028View on ClinicalTrials.gov

Age and Gender Effects on the Pharmacokinetics of BAY85-3934

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Anemia

Interventions

DRUG

BAY85-3934

Single doses of 20 mg BAY85-3934 as tablet

DRUG

Placebo

Single dose of placebo tablet matching the 20 mg BAY85-3934 tablet

Trial Locations (1)

58104

Fargo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY